Blocking PDE4B can not only reduce myocardial cell death, but also improve coronary microvascular obstruction, which provides the dual cardiac protection (140), and offers a novel perspective for preventing and treating MI/RI. The gene discussed is PDE4B; the disease is myocardial infarction.